Overview
Infection and Drug Resistance, published by Dove Medical Press (New Zealand), published 3,153 papers in 2021–2025, and its papers received 34,524 citations in those years. Its h-index is 95 and its two-year mean citedness is 2.75. On the ITS Journal Score it ranks #3,572 of 62,158 ranked journals and #365 of 1,066 in Biochemistry, Genetics and Molecular Biology.
Key figures
Citations count every citation the journal's papers received in these years, including citations to older papers. Two-year mean citedness is OpenAlex's measure of how often recent papers are cited; it is similar in idea to, but not the same as, an impact factor.
Papers and citations by year
| Year | Papers | Citations received | Open-access papers |
|---|---|---|---|
| 2020 | 470 | 14,852 | 470 |
| 2021 | 551 | 12,208 | 551 |
| 2022 | 735 | 9,895 | 735 |
| 2023 | 705 | 7,933 | 705 |
| 2024 | 563 | 2,853 | 563 |
| 2025 | 599 | 1,635 | 599 |
What it publishes
The leading research topics of its papers (OpenAlex topic classification). Select a topic to find other journals that publish on it.
Similar journals
Ranked journals that publish on the same topics.
| Journal | Field | Score | Papers 2021–2025 | Open access |
|---|---|---|---|---|
| Journal of Global Antimicrobial Resistance | Biochemistry, Genetics and Molecular Biology | 73.9 | 1,634 | 100% |
| Antibiotics | Biochemistry, Genetics and Molecular Biology | 85.8 | 7,688 | 100% |
| JAC-Antimicrobial Resistance | Immunology and Microbiology | 70.5 | 1,462 | 100% |
| Diagnostic Microbiology and Infectious Disease | Biochemistry, Genetics and Molecular Biology | 73.9 | 1,436 | 40% |
| International Journal of Antimicrobial Agents | Medicine | 81.5 | 1,526 | 36% |
| Annals of Clinical Microbiology and Antimicrobials | Biochemistry, Genetics and Molecular Biology | 79.8 | 432 | 100% |
| Journal of Antimicrobial Chemotherapy | Medicine | 83.4 | 2,343 | 60% |
| Microbial Drug Resistance | Biochemistry, Genetics and Molecular Biology | 67.1 | 427 | 12% |
Compare with similar journals (side by side with the two closest journals above)
Identity and sources
- ISSN-L: 1178-6973
- Print ISSN: 1178-6973
- Publisher: Dove Medical Press
- Listed in DOAJ: Yes (checked against DOAJ)
- Crossref: ISSN found in Crossref
- OpenAlex: S2765028195
- Journal website: www.dovepress.com
Figures come from OpenAlex (papers, citations, h-index, topics), Crossref (ISSN check) and DOAJ (open-access listing and fees). They change as records are corrected, so treat them as a dated snapshot. This page does not state whether the journal is indexed in Scopus, Web of Science or PubMed.
Questions
What is the ITS Journal Score of Infection and Drug Resistance?
It is 76.3 out of 100, which places it #3,572 among ranked journals. The score combines citation impact (45%), h-index (35%) and size (20%) from open OpenAlex data.
What is the impact factor of Infection and Drug Resistance?
This site does not publish Journal Impact Factors, which belong to Clarivate. As an open alternative, its two-year mean citedness in OpenAlex is 2.75.
Is Infection and Drug Resistance open access?
100% of its papers from 2021–2025 are recorded as open access, and it is listed in DOAJ.
Does Infection and Drug Resistance charge a publication fee?
DOAJ records an article processing charge of US$4,320. Check the journal's website for the current fee and any waivers.